BMJ Launches Living Guidelines on Type 2 Diabetes: Cardio-Renal Risk Now Central to Therapy Decisions Read more about BMJ Launches Living Guidelines on Type 2 Diabetes: Cardio-Renal Risk Now Central to Therapy Decisions
Lilly’s Oral GLP-1 Orforglipron Meets Phase 3 Endpoints in Obesity and Diabetes, Regulatory Filings Planned Read more about Lilly’s Oral GLP-1 Orforglipron Meets Phase 3 Endpoints in Obesity and Diabetes, Regulatory Filings Planned
AASLD 2025: SGLT2 Inhibitors Linked to Lower Risk of Serious Liver Events in Cirrhosis Patients on Diuretics Read more about AASLD 2025: SGLT2 Inhibitors Linked to Lower Risk of Serious Liver Events in Cirrhosis Patients on Diuretics
UI Health Performs First FDA-Approved Islet Cell Transplant with Lantidra Read more about UI Health Performs First FDA-Approved Islet Cell Transplant with Lantidra
Glycemic Control and Technology Use Improve in US Patients With Type 1 Diabetes, but Disparities Persist Tags hBA1c Read more about Glycemic Control and Technology Use Improve in US Patients With Type 1 Diabetes, but Disparities Persist
Semaglutide Not Linked to Higher Risk of Diabetic Retinopathy or Eye Disorders, Meta-analysis Finds Read more about Semaglutide Not Linked to Higher Risk of Diabetic Retinopathy or Eye Disorders, Meta-analysis Finds
AI-Enabled Sensor and Coaching System Boosts Glycemic Outcomes, Cuts Medication Use in Type 2 Diabetes Read more about AI-Enabled Sensor and Coaching System Boosts Glycemic Outcomes, Cuts Medication Use in Type 2 Diabetes
App-Guided Insulin Dosing Improves Glucose Control With Once-Weekly Icodec in Type 2 Diabetes Tags Rapid acting Read more about App-Guided Insulin Dosing Improves Glucose Control With Once-Weekly Icodec in Type 2 Diabetes
Study Links Low Abscisic Acid to Diabetes and Smoking Risks Read more about Study Links Low Abscisic Acid to Diabetes and Smoking Risks
Composite biomarker predicts mortality risk in type 2 diabetes Read more about Composite biomarker predicts mortality risk in type 2 diabetes
